Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-15

Clinical Trial Update: Immune Modulation Therapy for Pompe Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on an immune modulation therapy for Pompe disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pompe Disease | Phase 4 | Status: UNKNOWN